Rafferty Asset Management’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.7M | Sell |
|
|||||
|
2025
Q1 | $2.37M | Buy |
|
|||||
|
2024
Q4 | $2.89M | Sell |
|
|||||
|
2024
Q3 | $4.34M | Buy |
|
|||||
|
2024
Q2 | $3.71M | Sell |
|
|||||
|
2024
Q1 | $9.35M | Buy |
|
|||||
|
2023
Q4 | $9.65M | Sell |
|
|||||
|
2023
Q3 | $11.4M | Buy |
|
|||||
|
2023
Q2 | $4.77M | Sell |
|
|||||
|
2023
Q1 | $5.09M | Buy |
|
|||||
|
2022
Q4 | $4.09M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $1.62M | Buy |
|
|||||
|
2021
Q3 | $1.65M | Sell |
|
|||||
|
2021
Q2 | $2.19M | Buy |
|
|||||
|
2021
Q1 | $3.15M | Buy |
|
|||||
|
2020
Q4 | $784K | Sell |
|
|||||
|
2020
Q3 | $758K | Buy |
|